The German pharmaceutical giant Schering AG is in for a hard time. Androcur and Diane 35, 2 of its best-selling drugs marketed in Europe, are suspected to be potential causes of cancer. Tests carried out on rodents by the Federal Institute for Medication and Medical Products revealed a possible carcinogenic effect from a substance called cypoteron-acetate in the drugs. Consequently, in mid-August, German health authorities asked the company to retest the drugs. A Schering spokesperson, however, says that "you can't make any connection to humans from those tests".
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.